InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (1 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
1
T+90 hit rate
100%
T+90 mean return
+49.3%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Mayer Arie, Director. Insider active across 1 company, notably Oramed Pharmaceuticals INC.. Cumulatively, 9 disclosures have been recorded. Breakdown: 1 buy · 1 sell. Total volume traded: €77k. History available since 1 November 2021. The latest transaction was disclosed on 3 April 2023 (Acquisition). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Mayer Arie
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations9 total
30,000 sharesCommon StockSEC:0001213900-26-001275:0
30,000 sharesCommon StockSEC:0001213900-25-052624:0
30,000 sharesCommon StockSEC:0001209191-24-001137:0
30,000 sharesCommon StockSEC:0001209191-23-024935:0
5,009 shares@ US$2.2213.3% of flowCommon StockSEC:0001209191-23-022815:0
Canonical exit: 2 Jul 2023 (T+90)
12,000 sharesCommon StockSEC:0001209191-22-043771:0
6,000 sharesCommon StockSEC:0001213900-22-025289:0
3,000 shares@ US$25.6086.7% of flowCommon StockSEC:0001213900-22-025288:0
6,000 sharesCommon StockSEC:0001213900-22-000820:0
9 of 9 declarations
About Mayer Arie
Mayer Arie is Administrateur at Oramed Pharmaceuticals INC. (XNAS) and is also listed there as Director. The record shows 9 filings in total, and across the 9 sampled filings between 2022-01-05 and 2026-01-05, the aggregated amounts are EUR 10190 in buys and EUR 66455 in sells, with the modal transaction nature listed as Attribution.
